Vycor Medical Inc (VYCO) stock
VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.07+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.24MP/E –Yield –
Vycor Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Vycor Medical's profit margin for the twelve months ending Jun 30, 2026 was -3.3%. For fiscal 2025 it was -3.9%, against -6.7% the year before. The highest annual figure on record is -3.9% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3.9% | +2.9 |
| FY2024 | Dec 31, 2024 | -6.7% | −2.0 |
| FY2023 | Dec 31, 2023 | -4.8% | +28.3 |
| FY2022 | Dec 31, 2022 | -33.1% | −1.8 |
| FY2021 | Dec 31, 2021 | -31.3% | +40.7 |
| FY2020 | Dec 31, 2020 | -72.0% | −14.9 |
| FY2019 | Dec 31, 2019 | -57.2% | +34.2 |
| FY2018 | Dec 31, 2018 | -91.4% | +15.3 |
| FY2017 | Dec 31, 2017 | -106.6% | +7.1 |
| FY2016 | Dec 31, 2016 | -113.7% | +69.2 |
| FY2015 | Dec 31, 2015 | -182.9% | +141.0 |
| FY2014 | Dec 31, 2014 | -323.9% | −99.5 |
| FY2013 | Dec 31, 2013 | -224.4% | +18.8 |
| FY2012 | Dec 31, 2012 | -243.2% | +248.7 |
| FY2011 | Dec 31, 2011 | -491.9% | +135.0 |
| FY2010 | Dec 31, 2010 | -626.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -5.3% | −10.1 |
| Q1 FY2026 | Mar 31, 2026 | 4.4% | +13.2 |
| Q4 FY2025 | Dec 31, 2025 | -15.0% | −13.6 |
| Q3 FY2025 | Sep 30, 2025 | 1.0% | +16.3 |
| Q2 FY2025 | Jun 30, 2025 | 4.8% | +7.3 |
| Q1 FY2025 | Mar 31, 2025 | -8.8% | +0.2 |
| Q4 FY2024 | Dec 31, 2024 | -1.5% | +28.7 |
| Q3 FY2024 | Sep 30, 2024 | -15.3% | +1.5 |
| Q2 FY2024 | Jun 30, 2024 | -2.5% | −16.6 |
| Q1 FY2024 | Mar 31, 2024 | -9.1% | −11.0 |
| Q4 FY2023 | Dec 31, 2023 | -30.2% | +12.8 |
| Q3 FY2023 | Sep 30, 2023 | -16.8% | +20.2 |
| Q2 FY2023 | Jun 30, 2023 | 14.2% | +44.4 |
| Q1 FY2023 | Mar 31, 2023 | 1.9% | +25.7 |
| Q4 FY2022 | Dec 31, 2022 | -43.0% | +25.4 |
| Q3 FY2022 | Sep 30, 2022 | -37.0% | −38.2 |
| Q2 FY2022 | Jun 30, 2022 | -30.2% | −28.3 |
| Q1 FY2022 | Mar 31, 2022 | -23.8% | +58.4 |
| Q4 FY2021 | Dec 31, 2021 | -68.3% | +0.4 |
| Q3 FY2021 | Sep 30, 2021 | 1.1% | +73.0 |
| Q2 FY2021 | Jun 30, 2021 | -1.9% | +100.0 |
| Q1 FY2021 | Mar 31, 2021 | -82.1% | −29.2 |
| Q4 FY2020 | Dec 31, 2020 | -68.7% | −2.0 |
| Q3 FY2020 | Sep 30, 2020 | -71.9% | −6.9 |
| Q2 FY2020 | Jun 30, 2020 | -101.9% | −56.9 |
| Q1 FY2020 | Mar 31, 2020 | -53.0% | −1.6 |
| Q4 FY2019 | Dec 31, 2019 | -66.7% | +46.4 |
| Q3 FY2019 | Sep 30, 2019 | -64.9% | −31.6 |
| Q2 FY2019 | Jun 30, 2019 | -45.0% | +93.8 |
| Q1 FY2019 | Mar 31, 2019 | -51.4% | +49.1 |
| Q4 FY2018 | Dec 31, 2018 | -113.0% | +26.0 |
| Q3 FY2018 | Sep 30, 2018 | -33.4% | +79.7 |
| Q2 FY2018 | Jun 30, 2018 | -138.8% | −21.5 |
| Q1 FY2018 | Mar 31, 2018 | -100.5% | −27.5 |
| Q4 FY2017 | Dec 31, 2017 | -139.0% | +1.3 |
| Q3 FY2017 | Sep 30, 2017 | -113.0% | −11.1 |
| Q2 FY2017 | Jun 30, 2017 | -117.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -73.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -140.3% | – |
| Q3 FY2016 | Sep 30, 2016 | -101.9% | – |
See a number that looks wrong?